128 related articles for article (PubMed ID: 22613376)
1. [Relationship between serum visfatin level and children and adolescent obesity and non-alcoholic fatty liver disease].
Wen H; Wang HJ; Dong B; Ma J
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Mar; 33(3):269-72. PubMed ID: 22613376
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of serum visfatin concentrations in children with nonalcoholic fatty liver disease].
Romanowska A; Lebensztejn DM
Pol Merkur Lekarski; 2010 Jun; 28(168):459-61. PubMed ID: 20642104
[TBL] [Abstract][Full Text] [Related]
3. Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.
Auguet T; Terra X; Porras JA; Orellana-Gavaldà JM; Martinez S; Aguilar C; Lucas A; Pellitero S; Hernández M; Del Castillo D; Richart C
Clin Biochem; 2013 Feb; 46(3):202-8. PubMed ID: 23174488
[TBL] [Abstract][Full Text] [Related]
4. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease.
Sayın O; Tokgöz Y; Arslan N
J Pediatr Endocrinol Metab; 2014 May; 27(5-6):479-84. PubMed ID: 24468600
[TBL] [Abstract][Full Text] [Related]
5. Low 25-hydroxyvitamin D level is associated with insulin sensitivity in obese adolescents with non-alcoholic fatty liver disease.
Pirgon O; Cekmez F; Bilgin H; Eren E; Dundar B
Obes Res Clin Pract; 2013; 7(4):e275-83. PubMed ID: 24306155
[TBL] [Abstract][Full Text] [Related]
6. Serum visfatin level as a noninvasive marker for nonalcoholic fatty liver disease in children and adolescents with obesity: relation to transient elastography with controlled attenuation parameter.
Elkabany ZA; Hamza RT; Ismail EAR; Elsharkawy A; Yosry A; Musa S; Khalaf MA; Elgawesh RM; Esmat G
Eur J Gastroenterol Hepatol; 2020 Aug; 32(8):1008-1016. PubMed ID: 31834057
[TBL] [Abstract][Full Text] [Related]
7. Relationship between left ventricular mass and carotid intima media thickness in obese adolescents with non-alcoholic fatty liver disease.
Sert A; Pirgon O; Aypar E; Yilmaz H; Odabas D
J Pediatr Endocrinol Metab; 2012; 25(9-10):927-34. PubMed ID: 23426822
[TBL] [Abstract][Full Text] [Related]
8. Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children.
Ooi SQ; Chan RM; Poh LK; Loke KY; Heng CK; Chan YH; Gan SU; Lee KO; Lee YS
Pediatr Obes; 2014 Apr; 9(2):81-91. PubMed ID: 23447513
[TBL] [Abstract][Full Text] [Related]
9. Visfatin levels in nonalcoholic fatty liver disease.
Akbal E; Koçak E; Taş A; Yüksel E; Köklü S
J Clin Lab Anal; 2012 Feb; 26(2):115-9. PubMed ID: 22467327
[TBL] [Abstract][Full Text] [Related]
10. Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents.
Torun E; Gökçe S; Ozgen İT; Aydın S; Cesur Y
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):667-75. PubMed ID: 24706428
[TBL] [Abstract][Full Text] [Related]
11. Serum visfatin levels are decreased in schoolchildren with atopic asthma.
Machura E; Ziora K; Ziora D; Świtęochowska E; Halkiewicz F; Oświęcimska J; Kasperska-Zając A
Neuro Endocrinol Lett; 2012; 33(5):559-64. PubMed ID: 23090276
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum neopterin levels and its relationship with adipokines in pediatric obesity-related nonalcoholic fatty liver disease and healthy adolescents.
Arslan N; Tokgoz Y; Kume T; Bulbul M; Sayın O; Harmancı D; Akdogan GG
J Pediatr Endocrinol Metab; 2013; 26(11-12):1141-7. PubMed ID: 23740679
[TBL] [Abstract][Full Text] [Related]
13. Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol.
Jin H; Jiang B; Tang J; Lu W; Wang W; Zhou L; Shang W; Li F; Ma Q; Yang Y; Chen M
Diabetes Res Clin Pract; 2008 Mar; 79(3):412-8. PubMed ID: 18241953
[TBL] [Abstract][Full Text] [Related]
14. P-selectin, endocan, and some adhesion molecules in obese children and adolescents with non-alcoholic fatty liver disease.
Ustyol A; Aycan Ustyol E; Gurdol F; Kokali F; Bekpınar S
Scand J Clin Lab Invest; 2017 May; 77(3):205-209. PubMed ID: 28318371
[TBL] [Abstract][Full Text] [Related]
15. A meal high in saturated fat evokes postprandial dyslipemia, hyperinsulinemia, and altered lipoprotein expression in obese children with and without nonalcoholic fatty liver disease.
Mager DR; Mazurak V; Rodriguez-Dimitrescu C; Vine D; Jetha M; Ball G; Yap J
JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):517-28. PubMed ID: 23223552
[TBL] [Abstract][Full Text] [Related]
16. Adipokines and cytokines in non-alcoholic fatty liver disease.
Jarrar MH; Baranova A; Collantes R; Ranard B; Stepanova M; Bennett C; Fang Y; Elariny H; Goodman Z; Chandhoke V; Younossi ZM
Aliment Pharmacol Ther; 2008 Mar; 27(5):412-21. PubMed ID: 18081738
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.
Kodhelaj K; Resuli B; Petrela E; Malaj V; Jaze H
Minerva Pediatr; 2014 Feb; 66(1):23-30. PubMed ID: 24608579
[TBL] [Abstract][Full Text] [Related]
18. Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease.
Genc H; Dogru T; Kara M; Tapan S; Ercin CN; Acikel C; Karslioglu Y; Bagci S
Ann Hepatol; 2013; 12(4):548-55. PubMed ID: 23813132
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China].
Zhou X; Hou DQ; Duan JL; Sun Y; Cheng H; Zhao XY; Liu JT; Yang P; Shan XY; Mi J
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 May; 34(5):446-50. PubMed ID: 24016432
[TBL] [Abstract][Full Text] [Related]
20. Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease.
Lebensztejn DM; Białokoz-Kalinowska I; Kłusek-Oksiuta M; Tarasów E; Wojtkowska M; Kaczmarski M
Adv Med Sci; 2014 Mar; 59(1):81-4. PubMed ID: 24797980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
